testril 50 50mg tablet
a-z market enterprises developers inc - sildenafil (as citrate) - tablet - 50mg
meriva 1 g powder for injection
claris lifesciences phils inc - meropenem (as trihydrate) - powder for injection - 1 g
merop 1 g powder for injection
united labs inc - meropenem (as trihydrate) - powder for injection - 1 g
apvma open use permit 13785- lures, attractants, pheromones & toxicants/ fruit fly monitoring & trapping
apvma permit - hydroxyphenylbutanone acetate+acetic acid+ammonium acetate + others - unspecified class
alacare
link pharmaceuticals ltd - aminolevulinic acid hydrochloride 10.2mg equivalent to aminolevulinic acid 8mg - dermal patch - 8 mg - active: aminolevulinic acid hydrochloride 10.2mg equivalent to aminolevulinic acid 8mg excipient: durotak 387-2353 scotchpak 1109 (baking film) pegoterate - treatment of mild to moderate actinic ketatoses (ak) lesions on the face and scalp.
hexvix hexaminolevulinate (as hydrochloride) 85 mg powder for intravesical solution vial plus diluent vial
juno pharmaceuticals pty ltd - hexaminolevulinate hydrochloride -
lumexia methyl aminolevulinate 160 mg/g cream tube
galderma australia pty ltd - methyl aminolevulinate hydrochloride, quantity: 200 mg/g (equivalent: methyl aminolevulinate, qty 160 mg/g) - cream - excipient ingredients: self-emulsifying glyceryl monostearate; cetostearyl alcohol; peg-40 stearate; methyl hydroxybenzoate; propyl hydroxybenzoate; disodium edetate; glycerol; white soft paraffin; cholesterol; isopropyl myristate; arachis oil; almond oil; oleyl alcohol; purified water - treatment of thin or non-hyperkeratotic and non-pigmented actinic keratoses on the face and scalp when other registered therapies are unacceptable. primary treatment of superficial and/or nodular basal cell carcinoma where surgery is considered inappropriate. treatment of biopsy-proven squamous cell carcinoma in situ (bowen's disease), where surgery is considered inappropriate. lumexia is indicated in adults above 18 years of age.
alacare 5-aminolevulinic acid hydrochloride 8 mg dermal patch sachet
link medical products pty ltd t/a link pharmaceuticals - aminolevulinic acid hydrochloride, quantity: 10.2 mg (equivalent: aminolevulinic acid, qty 8 mg) - patch, dermal - excipient ingredients: polyethylene terephthalate; polyethylene; aluminium; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - treatment of mild to moderate actinic keratoses (ak) lesions on the face and scalp (hairless areas).
fluorescein serb fluorescein sodium 500mg/5ml injection solution ampoule
clinect pty ltd - fluorescein sodium, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections - fluorescein angiography of the fundus and of the iris vasculature. this medicinal product is for diagnostic use only.
hexvix 85mg powder and solvent for intravesical solution vials
photocure asa - hexaminolevulinate hydrochloride - powder and solvent for intravesical solution - 85mg